Kidney Function Tests Market Forecasts to 2028 – Global Analysis By Type (Kidney Biopsy, Dilution and Concentration Tests, Imaging Tests), Factor (Diabetes, High Blood Pressure, Kidney Stones), and By Geography
According to Stratistics MRC, the Global Kidney Function Tests Market is accounted for $760.97 million in 2021 and is expected to reach $1312.64 million by 2028 growing at a CAGR of 8.1% during the forecast period. Kidney function tests are procedures that usually use either the blood or urine to help identify issues in the kidneys. These tests are performed to check if the kidneys are filtering waste products too slowly and to see if the kidneys are leaking proteins into the urine. Regular kidney function tests help to identify issues in the early stages, making it possible to halt the progress of the disease.
Market Dynamics:
Driver:
Increasing expansions in diagnostic testing methods for early diagnosis of renal disorders
Due to growing developments in diagnostic testing methods for the initial diagnosis of renal disorders or diseases affecting kidney function are driving revenue growth in the market. For example, when compared to current practice using laboratory blood tests, point-of-care (POC) creatinine testing for the identification and monitoring of chronic kidney disease delivers enhanced accuracy and value in the monitoring and early identification of CKD. Rapid creatinine level results from such PoC testing deliver immediate input and information to the patient. This type of testing delivers real-time kidney function updates, which are essential for dose adjustments owing to renal impairment. They also offer rapid and accurate home testing, which allows for continuous monitoring, early diagnosis, and management of the deteriorated renal function. These factors are anticipated to drive revenue growth in the market.
Restraint:
Stringent government regulations
The stringent government guidelines leading to the use of specific methods in kidney tests may restrain the market revenue growth. The kidney is a very important organ of the human body and to examine any Chronic Kidney Disease (CKD) in an individual, a kidney test function is needed. Therefore, the function test has to follow many strict government regulations and also undergo strict regulations for approval. For instance, if a patient has a CKD and needs to undergo a kidney transplant, the patient, as well as the hospitals, needs to follow proper documentation or bonds under the laws of the government, which might be challenging.
Opportunity:
Emergent Market
Public-private organizations are working to make kidney disease diagnostics more reachable in key areas. Diabetic patients are tested for kidney damage regularly according to the new guidelines. These activities are anticipated to generate a favourable environment for market expansion. An increase in the incidence and prevalence of chronic kidney disease across the world is a creating opportunity for the growth market.
Threat:
Low precision of prediction models based on kidney function tests and overuse of kidney function tests
The Cockcroft-Gault [C-G] and Modification of Diet in Renal Disease [MDRD] equations are two key expectation equations for adults based on serum creatinine readings from kidney function tests. These prediction equations based on kidney function tests are found to be incorrect in the case of patients with normal and near-normal kidney function, which may lead to misdiagnosis and inaccurate assessment of renal function in patients. Moreover, overuse of tests delivers little value to patients and increases the cost strain on healthcare systems. These factors are predicted to threaten market revenue growth.
Urine Tests segment is expected to be the largest during the forecast period
The urine tests segment is anticipated to expand at a rapid pace during the forecast period which can be accredited to the ease in sample collection and very low risk of infection. The increasing use of urine dipstick analysis, the convenience of sample collection compared to blood tests that can cause discomfort and swelling, and the shallow risk of infection owing to sample collection can all be related to the significant share of the urine test segment’s rapid growth rate.
The hospitals segment is expected to have the highest CAGR during the forecast period
The hospitals segment held the largest market share. This high share is accredited to growing hospital visits owing to the rising awareness about CKD and its treatment. Besides, the development of sophisticated infrastructures across numerous provinces, which help in performing efficient diagnostic procedures, will contribute to the segment’s share. Moreover, the growing number of awareness campaigns about kidney function tests and the growing focus of emerging economies on increasing the number of hospitals.
Region with highest share:
The Asia Pacific is projected to hold the highest market share, owing to the fast-developing healthcare facilities and rise in investments by leading market players. Besides, the existence of a large target population in emerging countries, such as China and India, is expected to drive the regional market during the forecast period. Additionally, an increase in the number of high blood pressure and diabetes patients, who develop chronic kidney diseases, a rise in health awareness, and a surge in demand for advanced diagnostic and therapeutic regimens for chronic kidney diseases in the province are motivating the market growth.
Region with highest CAGR:
North America is projected to have the highest CAGR, owing to well-established healthcare infrastructure, high awareness levels about CKD, and favourable reimbursement policies & government initiatives. Moreover, the local presence of major market players and the easy availability of technologically advanced products. Additionally, high prevalence of the disease, especially in the U.S., and high affordability and awareness levels of the people in this province.
Key players in the market:
Some of the key players profiled in the Kidney Function Tests Market include Abbott, Acon Laboratories, Arkray, Baxter International Inc, Cook Medical, Danaher Corporation (Beckman Coulter, Inc), F. Hoffmann-La Roche, Laboratory Corporation of America Holdings (LabCorp), Nova Biomedical, Opti Medical, Quest Diagnostics, Randox Laboratories, Siemens Healthineers, Sysmex, Urit Medical, Bio-Techne Corporation, Eurofins Viracor, Horizon Therapeutics plc.
Key developments:
In Apr-2020: Nova Biomedical announced the addition of PT/INR testing to its Allegro capillary blood analyzer for point-of-care testing in primary care settings. This update enables the company to supervise patient coagulation therapy along with the testing for glycemic control, anaemia, kidney function, gout, and cardiac risk with a full lipids panel..
In March 2021: Bio-Techne Corporation announced that it published positive preliminary data on its kidney transplant rejection test, ExoTRU (Exosome Transplant Rejection Urine) stating that it is capable of discriminating between types of kidney rejection, providing critical information to assist clinician decision making and optimizing patient care.
In March 2020: Horizon Therapeutics plc announced the launch of “Down and Out Kidney”, a campaign to highlight the damaging effects associated with the accumulation of uric acid and gout in people with chronic kidney disease (CKD).
In Jul-2019: LabCorp expanded its Pixel by LabCorp platform. This latest offering enables users to buy testing online, visit a convenient LabCorp patient service centre (PSC) for sample collection by a LabCorp phlebotomist, and get confidential results via a safe online portal.
Types Covered:
• Kidney Biopsy
• Dilution and Concentration Tests
• Imaging Tests
• Blood Tests
• Urine Tests
Factors Covered:
• Diabetes
• High Blood Pressure
• Kidney Stones
• Cardiovascular Disease
• Enlarged Prostate or Lupus
• Acute Kidney Injury
Products Covered:
• Dipsticks
• Disposables
• Instruments
• Kits and Assay
• Reagents
• Software
Diseases Covered:
• Chronic
• Acute
End Users Covered:
• Hospitals & Clinics
• Ambulatory Surgical Centers
• Diagnostic Laboratories
• Research Laboratories and Institutes
Regions Covered:
• North America
US
Canada
Mexico
• Europe
Germany
UK
Italy
France
Spain
Rest of Europe
• Asia Pacific
Japan
China
India
Australia
New Zealand
South Korea
Rest of Asia Pacific
• South America
Argentina
Brazil
Chile
Rest of South America
• Middle East & Africa
Saudi Arabia
UAE
Qatar
South Africa
Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2020, 2021, 2022, 2025 and 2028
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
Comprehensive profiling of additional market players (up to 3)
SWOT Analysis of key players (up to 3)
• Regional Segmentation
Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook